Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Seeking Alpha • Nov 11, 2025

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Seeking Alpha • May 30, 2025

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Seeking Alpha • Feb 25, 2025

4 Best-Performing Sector ETFs of June

We have highlighted four top-performing ETFs from different sectors that have led the way in June.

Zacks Investment Research • Jul 2, 2024

Biotech ETFs Stage Solid Comeback at the Start of 2024

The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.

Zacks Investment Research • Jan 9, 2024

5 Least-Hurt Biotech ETFs of the Last Week

Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.

Zacks Investment Research • Feb 15, 2023

Can Health Care Stocks Outperform Again In 2023?

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

Seeking Alpha • Jan 11, 2023

2 Sector ETFs Hovering Around a 52-Week High

We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.

Zacks Investment Research • Dec 6, 2022

5 Best Areas of Q3 of 2022 & Their Top ETFs

These ETF areas won in the third quarter of 2022.

Zacks Investment Research • Sep 27, 2022

Biotech Wins Last Week: 5 Best ETFs

The biotech corner of the broad healthcare sector outperformed last week on speculation over a takeover bid for Global Blood Therapeutics.

Zacks Investment Research • Aug 8, 2022